Advances of target therapy on NOTCH1 signaling pathway in T-cell acute lymphoblastic leukemia
Open Access
- 13 November 2020
- journal article
- review article
- Published by Springer Nature in Experimental Hematology & Oncology
- Vol. 9 (1) , 1-9
Abstract
T-cell acute lymphoblastic leukemia (T-ALL) is one of the hematological malignancies. With the applications of chemotherapy regimens and allogeneic hematopoietic stem cell transplantation, the cure rate of T-ALL has been significantly improved. However, patients with relapsed and refractory T-ALL still lack effective treatment options. Gene mutations play an important role in T-ALL. The NOTCH1 gene mutation is the important one among these genetic mutations. Since the mutation of NOTCH1 gene is considered as a driving oncogene in T-ALL, targeting the NOTCH1 signaling patheway may be an effective option to overcome relapsed and refractory T-ALL. This review mainly summarizes the recent research advances of targeting on NOTCH1 signaling pathway in T-ALL.Keywords
Funding Information
- National Natural Science Foundation of China (81800137)
This publication has 66 references indexed in Scilit:
- The NOTCH signaling pathway: role in the pathogenesis of T-cell acute lymphoblastic leukemia and implication for therapyTherapeutic Advances in Hematology, 2013
- Interconnecting molecular pathways in the pathogenesis and drug sensitivity of T-cell acute lymphoblastic leukemiaBlood, 2010
- Acute T-cell leukemias remain dependent on Notch signaling despite PTEN and INK4A/ARF lossBlood, 2010
- Regulation of PTEN by CK2 and Notch1 in primary T-cell acute lymphoblastic leukemia: rationale for combined use of CK2- and -secretase inhibitorsHaematologica, 2009
- Direct inhibition of the NOTCH transcription factor complexNature, 2009
- Targeting the Notch1 and mTOR pathways in a mouse T-ALL modelBlood, 2009
- NOTCH inhibition and glucocorticoid therapy in T-cell acute lymphoblastic leukemiaLeukemia, 2009
- The Canonical Notch Signaling Pathway: Unfolding the Activation MechanismCell, 2009
- Notch signaling mediates G1/S cell-cycle progression in T cells via cyclin D3 and its dependent kinasesBlood, 2009
- γ-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemiaNature Medicine, 2008